Poseida Therapeutics, Inc. (PSTX)
NASDAQ: PSTX · IEX Real-Time Price · USD
3.190
-0.155 (-4.63%)
May 17, 2024, 4:00 PM EDT - Market closed
Poseida Therapeutics Market Cap
Poseida Therapeutics has a market cap or net worth of $310.26 million as of May 17, 2024. Its market cap has increased by 15.90% in one year.
Market Cap
310.26M
Enterprise Value
196.18M
1-Year Change
15.90%
Ranking
Category
Stock Price
$3.19
Market Cap Chart
Since July 10, 2020, Poseida Therapeutics's market cap has decreased from $948.90M to $310.26M, a decrease of -67.30%. That is a compound annual growth rate of -25.17%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 17, 2024 | 309.30M | -4.63% |
May 16, 2024 | 324.30M | -3.34% |
May 15, 2024 | 335.50M | 18.51% |
May 14, 2024 | 283.10M | 4.43% |
May 13, 2024 | 271.10M | 6.23% |
May 10, 2024 | 255.20M | -2.41% |
May 9, 2024 | 261.50M | - |
May 8, 2024 | 261.50M | -7.17% |
May 7, 2024 | 281.70M | 3.15% |
May 6, 2024 | 273.10M | -1.37% |
May 3, 2024 | 276.90M | 2.86% |
May 2, 2024 | 269.20M | 0.71% |
May 1, 2024 | 267.30M | 14.48% |
Apr 30, 2024 | 233.50M | 4.29% |
Apr 29, 2024 | 223.90M | 8.95% |
Apr 26, 2024 | 205.50M | 3.89% |
Apr 25, 2024 | 197.80M | -0.95% |
Apr 24, 2024 | 199.70M | -4.17% |
Apr 23, 2024 | 208.40M | 0.24% |
Apr 22, 2024 | 207.90M | 6.67% |
Apr 19, 2024 | 194.90M | 0.98% |
Apr 18, 2024 | 193.00M | -1.93% |
Apr 17, 2024 | 196.80M | 0.46% |
Apr 16, 2024 | 195.90M | -16.46% |
Apr 15, 2024 | 234.50M | -10.97% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Atai Life Sciences | 343.20M |
Fractyl Health | 342.33M |
DocGo | 341.26M |
Inovio Pharmaceuticals | 338.65M |
Nektar Therapeutics | 336.03M |
Tenaya Therapeutics | 333.70M |
Verastem | 332.27M |
Caribou Biosciences | 328.76M |